Right, BooDog: The evidence that CTIX shares contain plenty of neglected, unrecognized value has never been stronger than it is now, and this is just beginning to be reflected by the progress now being made in the share price this week, after the recent lows. Kevetrin is the number one focus of interest, and the latest news is full of promise.